Back to Neurology
Neurologyv1.0Evidence-Based

Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)

Determines effectiveness of current migraine treatment plan to guide treatment optimization decisions

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mtoq 4 score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Migraine Treatment Optimization Questionnaire-4 (mTOQ-4) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

mTOQ-4 Score = Q1 + Q2 + Q3 + Q4 (where 0=never/rarely, 1=less than half the time, 2=half the time or more)

Clinical Pearls & Practice Notes

  • mTOQ-4 is a validated subset derived from the original mTOQ-6 questionnaire
  • Higher scores indicate better treatment optimization and lower risk of chronic migraine
  • Treatment modification should be considered for scores <8
  • The questionnaire assesses 4 key aspects: 2-hour pain freedom, 24-hour relief, ability to plan activities, and feeling in control
  • Should be reassessed periodically to monitor treatment effectiveness

Evidence & Literature Citations

  1. Lipton RB, Kolodner K, Bigal ME, Valade D, Láinez MJ, Pascual J, et al. Validity and reliability of the migraine-treatment optimization questionnaire. Cephalalgia. 2009 Jul;29(7):751-9. doi: 10.1111/j.1468-2982.2008.01786.x.
  2. Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015 Feb 17;84(7):688-95. doi: 10.1212/WNL.0000000000001256.
  3. Silberstein SD, Lipton RB, Dodick DW, Goadsby PJ, Freitag F, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 Feb;47(2):170-80.

Score Interpretation Ranges

Very Poor0 – 0 pts

Very poor treatment efficacy

Poor1 – 5 pts

Poor treatment efficacy

Moderate6 – 7 pts

Moderate treatment efficacy

Maximum8 – 8 pts

Maximum treatment efficacy

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.